SCHEMBL31056889

SCHEMBL31056889

C#[N+]c1ccccc1CC(OC)OC

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15773887 1.00 TDP1 (0.32) TDP1
SCHEMBL29922500 0.81 TDP1 (0.32) TDP1
SCHEMBL18658983 0.72 TAAR1 (0.43)
SCHEMBL31230581 0.71 HSPA5 (0.48)
SCHEMBL588658 0.71 ALDH1A1 (0.40) TDP1
SCHEMBL2478903 0.71 IDO1 (0.45)
SCHEMBL3211513 0.71 IDO1 (0.45) TDP1
SCHEMBL30719001 0.68 MGAM (0.36) TDP1
SCHEMBL25470111 0.67 TDP1 (0.35) TDP1
SCHEMBL10743250 0.67 LMNA (0.43) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed